Skip to main content
. 2022 Dec 8;13:1063679. doi: 10.3389/fimmu.2022.1063679

Figure 7.

Figure 7

Schematic representation of manufacturing process, immunogenicity and safety evaluation studies of BBV154 vaccine candidate.